CCK (2633), free acid, is a CCK peptide fragment designed to examine extended domain organization and receptor-interaction determinants. Its structure supports conformational analysis of mid-region motifs. Researchers apply it to evaluate peptide flexibility and motif relevance. The molecule aids mapping structural gradients across CCK-derived peptides.
CAT No: C21002
1. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
2. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
3. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More